NasdaqGS:SHCLife Sciences
Sotera Health (SHC) Margin Improvement To 6.7% Tests Bullish Profitability Narrative
Sotera Health (SHC) has just opened Q1 2026 reporting with trailing numbers that show total revenue of about US$1.2b over the last 12 months and basic EPS of US$0.27, alongside year over year earnings growth of 75.8%. Over the past reported quarters, revenue has ranged from US$254.5 million in Q1 2025 to US$311.3 million in Q3 2025, while quarterly basic EPS moved from a loss of US$0.05 in Q1 2025 to US$0.17 in Q3 2025, illustrating improving profit conversion as trailing net margin sits at...